Point of Care Diagnostics Market
完整報告名稱與涵蓋範圍
Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products (PT/INR, ACT/APTT), Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products, Other Products), By Mode of Purchase, By Technology, By Sample Type, By End User, Region, And Segment Forecasts, 2025-2034
報告摘要
In 2024, the Point of Care Diagnostics Market worldwide was assessed at USD 15.59 Billion. Analysts project it will develop to USD 34.68 Billion by 2034, at a CAGR of 8.4% spanning 2025 to 2034.
Point of Care Diagnostics covers diagnostic devices are used for early and quick diagnosis of diseases. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Point of Care Diagnostics Market Snapshot
Chapter 4. Global Point of Care Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Point of Care Diagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on POINT OF CARE DIAGNOSTICS MARKET Industry Trends
Chapter 5. Point of Care Diagnostics Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share by Products, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products:
5.2.1. Glucose Monitoring Products
5.2.1.1. Glucose Monitoring Strips
5.2.1.2. Glucose Monitoring Meters
5.2.1.3. Glucose Monitoring Lancets & Lancing Devices
5.2.2. Cardiometabolic Monitoring Products
5.2.2.1. Cardiac Marker Testing Products
5.2.2.2. Blood Gas/Electrolyte Testing Products
5.2.2.3. HbA1c Testing Products
5.2.3. Infectious Disease Testing Products
5.2.3.1. Respiratory Infection Testing Products
5.2.3.1.1. Influenza Testing Products
5.2.3.1.2. Tuberculosis
5.2.3.1.3. Other Respiratory Infections
5.2.3.2. Healthcare-Associated Infection Testing Products
5.2.3.3. Tropical Disease Testing Products
5.2.3.4. Sexually Transmitted Disease Testing Products
5.2.3.4.1. HIV Testing Products
5.2.3.4.2. Hepatitis Testing Products
5.2.3.4.3. Syphilis Testing Products
5.2.3.4.4. Human Papillomavirus Testing Products
5.2.3.4.5. Chlamydia trachomatis Testing Products
5.2.3.4.6. Neisseria gonorrhoeae Testing Products
5.2.3.4.7. Herpes Simplex Virus Testing Products
5.2.3.5. Clostridium difficile Infection Testing Products
5.2.3.6. Other Infectious Disease Testing Products
5.2.4. Coagulation Monitoring Products
5.2.4.1. PT/INR Testing Products
5.2.4.2. ACT/APTT Testing Products
5.2.5. Pregnancy & Fertility Testing Products
5.2.5.1. Pregnancy Testing Products
5.2.5.2. Fertility Testing Products
5.2.6. Tumor/Cancer Marker Testing Products
5.2.7. Urinalysis Testing Products
5.2.8. Cholesterol Testing Products
5.2.9. Hematology Testing Products
5.2.10. Drugs-of-Abuse Testing Products
5.2.11. Thyroid-Stimulating Hormone Testing Products
5.2.12. Fecal Occult Testing Products
5.2.13. Other Products
Chapter 6. Point of Care Diagnostics Market Segmentation 2: By Mode of Purchase, Estimates & Trend Analysis
6.1. Market Share by Mode of Purchase, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Mode of Purchase:
6.2.1. Prescription-Based Testing Products
6.2.2. Over-the-Counter (OTC) Testing Product
Chapter 7. Point of Care Diagnostics Market Segmentation 3: By Technology, Estimates & Trend Analysis
7.1. Market Share by Technology, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
7.2.1. Biochemistry
7.2.2. Immunoassays
7.2.3. Molecular Diagnostics
7.2.3.1. RT-PCR
7.2.3.2. INAAT
Chapter 8. Point of Care Diagnostics Market Segmentation 4: By Sample Type, Estimates & Trend Analysis
8.1. Market Share by Sample Type, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sample Type:
8.2.1. Blood Samples
8.2.2. Nasal & Oropharyngeal Swabs
8.2.3. Urine Samples
8.2.4. Other Samples
Chapter 9. Point of Care Diagnostics Market Segmentation 5: By End-users, Estimates & Trend Analysis
9.1. Market Share by End-users, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-users:
9.2.1. Home Care/Self Testing
9.2.2. Physician offices & Outpatient/Ambulatory Care Settings
9.2.3. Hospitals
9.2.4. Research Laboratories
Chapter 10. Point of Care Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Point of Care Diagnostics Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.2.3. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.2.4. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.5. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.2.6. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.3. Europe
10.3.1. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.3.3. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.3.4. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.5. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.3.6. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.4.3. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.4.4. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.4.5. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts By Sample Type, 2021-2034
10.4.6. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.5. Latin America
10.5.1. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.5.3. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.5.4. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.5. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.5.6. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.6.3. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.6.4. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.5. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.6.6. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Dickinson, And Company (Bd)
11.2.3. Chembio Diagnostic Systems, Inc.
11.2.4. Danaher Corporation
11.2.5. Ekf Diagnostics Holdings Plc
11.2.6. Werfenlife, S.A.
11.2.7. Johnson & Johnson Services, Inc.
11.2.8. Nova Biomedical
11.2.9. Hoffmann-La Roche Ltd.
11.2.10. Sekisui Chemical Co. Ltd.
11.2.11. Quidel Corporation
11.2.12. Siemens Ag
11.2.13. Trinity Biotech
11.2.14. Accubiotech Co., Ltd.
11.2.15. Other Key Players.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們